Shenzhen Bioeasy Biotechnology Co.,Ltd.’s Net Profit Dropped 24.2% in First Three Quarters of 2022

Shenzhen Bioeasy Biotechnology Co.,Ltd. (深圳市易瑞生物技术股份有限公司) (300942.SZ) reported a net profit of 148.3 million yuan in the first three quarters of 2022, down 24.2% year-on-year.

Meanwhile, the company posted 572.1 million yuan in revenue, up 32.7% year-on-year.

At the end of the reporting period, it had 1.3 billion yuan in total assets and 226 million yuan in total liabilities, with a liability-to-asset ratio of 17.9%.